Written by The Genomics Market is benefiting from the increasing adoption of personalized medicine. By analyzing genetic information, healthcare professionals can gain insights into disease risk and potential treatment responses. This approach is particularly relevant to oncology, rare diseases, and pharmacogenomics, where genetic differences can influence disease characteristics and therapeutic outcomes.
Precision and personalized medicine is projected to be one of the fastest-growing application areas, with MRFR forecasting a 13.1% CAGR through 2035. Increasing reimbursement opportunities and improvements in genomic interpretation are helping expand clinical adoption. Market Analysis indicates that integration between sequencing platforms, bioinformatics software, and healthcare systems will remain important for future development.
FAQ: What is personalized medicine?
It is an approach that uses individual characteristics, including genetic information, to help guide healthcare decisions.